PG-102 for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Sep 2025: Trial registered, NCT07187856

The trials

NCT07187856: Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus

State
Not started
Phase
Phase 2
People
80 planned
Started
Jan 2026
Primary completion
Sep 2026
Arms
PG-102
Results
None posted
  1. 23 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.